fomesafen has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbeau, A; Boyer, H; Buu, NT; Dallaire, L; de Lanney, LE; Irwin, I; Langston, EB; Langston, JW; Veilleux, F | 1 |
| Barbeau, A; Buu, NT; Dallaire, L; Poirier, J; Rucinska, E | 1 |
| Johannessen, JN; Markey, SP | 1 |
| Bedingham, W; Bruce, IC; Eastman, MJ; Tatton, WG; Verrier, MC | 1 |
| Kolomiets, BP; Lukhanina, EP; Shevko, GN | 1 |
| Kuno, S; Mizuta, E; Sasa, M; Yoshida, O; Yoshimura, N | 1 |
| Dietz, V | 1 |
1 review(s) available for fomesafen and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Reflex behavior and programming in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Electromyography; Haplorhini; Humans; Muscle Rigidity; Muscle Tonus; Muscles; Parkinson Disease; Parkinson Disease, Secondary; Postural Balance; Posture; Proprioception; Reflex | 1993 |
6 other study(ies) available for fomesafen and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain Chemistry; Catechol O-Methyltransferase Inhibitors; Catecholamines; Disease Models, Animal; Melanophores; Motor Activity; Movement; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Pyrogallol; Ranidae; Reflex; Salamandridae; Skin Pigmentation | 1985 |
Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Drug Interactions; Epinephrine; Melanophores; Motor Activity; Norepinephrine; Paraquat; Pargyline; Parkinson Disease, Secondary; Pigmentation; Posture; Pyridines; Pyridinium Compounds; Rana pipiens; Reflex | 1985 |
Assessment of the opiate properties of two constituents of a toxic illicit drug mixture.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analgesics, Opioid; Animals; Drug Combinations; Exploratory Behavior; Illicit Drugs; In Vitro Techniques; Male; Meperidine; Naloxone; Narcotics; Pharmacology; Pyridines; Rats; Receptors, Opioid; Reflex; Respiration | 1984 |
Defective utilization of sensory input as the basis for bradykinesia, rigidity and decreased movement repertoire in Parkinson's disease: a hypothesis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Afferent Pathways; Animals; Cats; Humans; Mechanoreceptors; Models, Neurological; Movement Disorders; Muscle Rigidity; Parkinson Disease; Primates; Pyridines; Reflex; Sensation | 1984 |
Participation of nucleus entopeduncularis in motor instrumental reflex and entopeduncular influences on motor thalamic nuclei in normal and MPTP-treated cats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cats; Corpus Striatum; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Electromyography; Male; Mesencephalon; Motor Neurons; Reflex; Substantia Nigra; Thalamic Nuclei | 1993 |
The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dopamine Agents; Ergolines; Macaca fascicularis; Male; Parkinson Disease, Secondary; Quinpirole; Reflex; Urinary Bladder; Urination | 1993 |